Logged in as a Visitor.
potassium voltage-gated channel, subfamily H (eag-related), member 5
The Kv10.2 channel (encoded by the KCNH5 gene) belongs to the ether-à-go-go (EAG) family within the voltage-gated potassium (Kv) channel superfamily. EAG channel family members, including both Kv10.1 and Kv10.2, are overexpressed in cancer and have been suggested as tumor markers as well as cancer therapeutic targets. Kv10.2 is natively expressed in the nervous system  The EAG family includes the eag (Kv10), erg (Kv11), and elk (Kv12) channel subfamilies, each sharing only ~20% amino acid identity to Kv1 channels in the voltage sensors. EAG family channels generally activate in a subthreshold voltage range with a relatively low apparent gating valence, but have highly variable gating kinetics , .
Kcnh5 : potassium voltage-gated channel, subfamily H (eag-related), member 5
Kv10 channel gating is that the activation rate is highly sensitive to divalent cations such as Mg2+ and Ni2+ ,. These ions preferentially slow the first independent transition and thus bind a closed conformation early in the activation pathway , . The binding site for divalent cations requires acidic residues in S2 and S3 that are unique to the EAG family . Silverman et al.  proposed that divalent cations electrostatically slow movement of the third S4 gating charge into an extracellular pocket and Schonherr et al.  proposed that Mg2+ slows activation sterically by narrowing the gating canal.
Recently, we identified a human Kv10.2 channel mutation (R327H) in a child with epileptic encephalopathy with seizures intractable to medical therapy and autistic features via exome sequencing. To understand how this R327H mutation, which substitutes a single residue within the voltage-sensing helix S4, affects the structure and function of Kv10.2, we performed this structural and functional study. 
Whole cell currents under our standard recording conditions (with 20 nM estimated free calcium in the pipette medium) showed a tendency to decline, with or without 2 mM ATP in the patch pipette. From initial current magnitudes observed at 
Upon expression in mammalian cells, quinidine blocked hEAG1 channels (IC50 1.4 WM) more potently than hEAG2 channels (IC50 152 WM), thus providing a useful tool for the functional distinction between hEAG1 and hEAG2 potassium channels 
Mutation at I345I residue
To investigate whether this residue plays a role in determining differ- ences in activation between heag1 and heag2 channels, we mutated the residue, I345L in heag1, and L345I in heag2. In neither case, though, did the mutation affect the activation kinetics: the heag1 mutant remained fast and the heag2 mutant remained slow. This therefore shows that this residue, and indeed the whole of the S4–S5 linker, do not participate in determining differences in activation kinetics between the two channels 
hEAG channels establish complex interactions with cytoskeletal elements, and that these interactions strong- ly influence the properties of the channels. We also con- clude that the electrophysiological changes observed during the cell cycle are most likely due to reorganiza- tion of the cytoskeleton during the G2/M transition
Structural modelling of Kv10.2 Arg327 in six states
Kv channels are membrane proteins that consist of six transmembrane segments, including S1–S4 as the VSD, a relative independent domain that transforms membrane potential changes into channel gating, and S5 and S6 as the pore-forming module. Sequence analysis shows that Arg327 is located in the critical S4 helix of the VSD (Fig. 1A). Within the S4 helix of VSD, Arg327, together with Lys325, Arg329, and Arg331 (commonly known as R[K]1–R4), are positively charged residues that sense changes in the membrane potential and produce a conformational change of the VSD, which in turn controls channel gating 
Similar to other Kv channels, the functional Eag channel is assumed to be a tetramer, each monomer consisting of six putative transmembrane domains, with the S4 domain serving as the main voltage sensor. In addition, they also possess long intracellular N- and C-termini , . The binding site for divalent cations requires acidic residues in S2 and S3 that are unique to the EAG family . The homologous residue Serine 321 in Kv10.2 contributes to effects of Mg2+ and Ni2+ .
Not only transmembrane spanning regions, but also non-membrane spanning regions are responsible for differences in the behaviour of the hEag1 and hEag2 potassium channels. 
Distribution of Kv10.2 on neuron
Both Kv10.1 and 10.2 channels are expressed largely in neurons and localized at synapses 
Distribution of Eag1 and Eag2 in Hippocampal neurons
Immunofluorescence studies using markers for different compartments of neurons demonstrated a differential expression pattern of rEag1 and rEag2 K+ channels in the somatodendritic region. Furthermore, rEag1 K+ channels were in close proximity to synaptophysin and densin-180, but not GAD65. Our data suggest that both rEag1 and rEag2 K+ channels may play a pivotal role in the regulation of the excitability of dendrites and somas, and that rEag1 K+ channels may modulate the postsynaptic signaling of glutamatergic synapses 
Kv10.2 expression in brain
The rat eag2 mRNA was predominantly expressed in neural tissue and was not detected in adult skeletal, cardiac, or smooth muscle. Within the brain, its distribution overlaps that of rat ether-a` -go-go1 in specific regions within the cortex and olfactory bulb, but was differentially distributed in other locations, being scanty within the cerebellum, and most notably present in the thalamus, inferior colliculus, and certain brainstem nuclei 
In the central nervous system, Eag2 levels are the most prominent in layer IV of the cerebral cortex, an area for which Eag2 has been proposed to participate in the regulation of the behavioral-state-dependent entry of sensory information (Saganich et al.,1999). Similar immunoreactivity patterns for Eag1 and Eag2 are observed in the granular layer of the dentate gyrus and pyramidal layers of the CA1, CA2, and CA3 subfields of the hippocampus 
Kv10.2 expression in body
The human genome has two isoforms of Eag channels, hEag1 (KCNH1, Kv10.1) and hEag2 (KCNH5, Kv10.2). Both are expressed mainly in the central nervous system, although hEag2 has also been found in skeletal muscle, heart, lung, liver, placenta, kidney and pancreas , .
Function in CNS
Although the functional role of Eag1, Eag2, and SK3 in the central nervous system remains undetermined, Eag2 mRNA downregulation might be related to hippocampal impairment of learning and memory 
The hippocampus has a well-established role in spatial learning and memory, and it may also regulate defensive behaviors related to anxiety. Recently, it was demonstrated that isolation-reared rats had reduced Eag2 mRNA expression in the hippocampus, prefrontal cortex, and striatum. This finding was related to a decrease in exploratory activity in a novel environment, suggesting the involvement of Eag2 in stress-related responses 
solated and socially reared rats were tested for exploratory activity in the open field test for 5 min and brains were processed for reverse-transcription coupled to quantitative polymerase chain reaction (qRT-PCR). Isolated reared rats showed decreased exploratory activity in the open field. Compared to socially reared rats, isolated rats showed reduced Htr2a mRNA expression in the striatum and brainstem and reduced Eag2 mRNA expression in all examined regions except cerebellum.
Medulloblastoma (MB) is the most common pediatric CNS malignancy. We identify EAG2 as an overexpressed potassium channel in MBs across different molecular and histological subgroups. EAG2 knockdown not only impairs MB cell growth in vitro, but also reduces tumor burden in vivo and enhances survival in xenograft studies. Therefore voltage-gated potassium channel EAG2 controls mitotic entry and tumor growth in medulloblastoma via regulating cell volume dynamics 
Voltage-gated potassium channel Kv10.2 (KCNH5) is expressed in the nervous system, but its functions and involvement in human disease are poorly understood. We studied a human Kv10.2 channel mutation (R327H) recently identified in a child with epileptic encephalopathy and autistic features 
Electrophysiology of rat eag2
REAG2-expressing cells, sustained outward currents were activated by depolarisation beyond -60 mV (Fig. 5A), and current amplitudes observed at +40 mV were 714 +or - 89 pA (n =17). The activation threshold was in the range of -60 mV with a half activation voltage at +10 + or - 3 mV and a slope of 19 + or -1 mV (n = 9). The rate of activation, from -80 mV, in the presence of 1.5 mM external Mg2+, was predominantly slow, but multiple time constants were present 
Heag1 and heag2 comparison
The activation rate depends on holding potential for both heag2 and heag1 (Fig. 4A,B); activation is faster for more positive holding potentials (Cole–Moore shift). At first glance the heag1 currents shown in Fig. 4B appear to activate more slowly than those for heag2 in Fig. 4A, at least at hyperpolarised potentials. However, closer analysis shows that in contrast to heag2 currents, the heag1 currents appear slower because they are initially sigmoidal, with an initial lag in channel opening, but that the subsequent time course (i.e. t20–80%) is in fact faster for heag1 ( Fig. 4C), at least for holding potentials in the range −100 mV to −60 mV 
In the Xenopus oocyte expression system the time course of activation was about four times slower and the voltage required for half-maximal subunit activation was about 10 mV greater for hEAG2 channels. However, its voltage dependence was smaller and, therefore, hEAG2 channels start to open at more negative voltages than hEAG1. Coexpression of both isoforms and kinetic analysis of the resulting currents indicated that they can form heteromeric channel complexes in which the slow activation phenotype of hEAG2 is dominant 
Heag1 and Heag2 in X oocytes
Sample normalized current traces showing the difference in activation times for heag1 and heag2 channels. The traces are shown for steps from holding potentials of )60 mV and )70 mV to a test potential of +40 mV; activation is slower for hyperpolarised potentials (not shown). The human eag channels (heag1 and heag2) are 73% homologous, and the membrane-spanning regions, the PAS domain and the cNBD domain are well conserved. We recently compared the functional properties of heag1 and heag2. We found that, compared with heag1, the conductance–voltage curve for heag2 was shifted to the left and the voltage sensitivity was less; also the activation kinetics were slower for heag2, and the sensitivity to blocking drugs was lower for heag2. ]
Factors effecting Kinetics
Eag channels, eag1 and eag2, are characterized by outward rectification without inactivation, and by fast deactivation and slow activation. The activation kinetics depend on the holding potential (‘‘Cole–Moore shift’’) and extracellular magnesium